Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Curr Mol Med ; 17(6): 389-404, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29256351

RESUMO

Helicobacter pylori infection (Hp-I) is a prevalent disorder identified in the majority of the population in many countries around the world and is responsible for substantial gastrointestinal morbidity. Likewise, neurodegenerative diseases such as Alzheimer's disease, Parkinson's diseases, multiple sclerosis or glaucoma defined as ocular Alzheimer's disease, are associated with a large public health burden and are among the leading causes of disability. Emerging evidences suggest that Hp-I may be associated with neurodegenerative conditions. Moreover, Hp-I could be a predictor of metabolic syndrome (MetS). Hp-I and its related MetS may induce gastrointestinal tract dys-motility disorders with systemic complications possibly including central nervous system neurodegenerative pathologies. We hereby explore the emerging role of Hprelated metabolic gastrointestinal dys-motilities on the molecular pathophysiology of Hprelated neurodegenerative and gastrointestinal disorders. Improving understanding of such Hp-I pathophysiology in brain pathologies may offer benefits by application of new relative therapeutic strategies including novel opportunities toward enhancing Hp eradication.


Assuntos
Gastroenteropatias/epidemiologia , Motilidade Gastrointestinal , Infecções por Helicobacter/complicações , Helicobacter pylori/patogenicidade , Doenças Neurodegenerativas/epidemiologia , Animais , Gastroenteropatias/microbiologia , Infecções por Helicobacter/microbiologia , Helicobacter pylori/isolamento & purificação , Humanos , Doenças Neurodegenerativas/microbiologia , Prevalência
4.
Curr Mol Med ; 11(8): 696-707, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21902649

RESUMO

A common characteristic of the central nervous system (CNS) neurodegenerative disorders is neuroinflammation, marked by augmented numbers of activated and primed microglia, increased inflammatory cytokines and decreased anti-inflammatory molecules. CNS neuroinflammation is a critical component in the progression of several neurodegenerative diseases which sensitize the brain to produce an exaggerated response to immune stimuli in the periphery. Neuroinflammation might initiate from the periphery and peripheral conditions through disrupted blood-brain barrier powerfully influence various brain pathologies. Gastrointestinal tract (GIT) represents a vulnerable area through which pathogens influence the brain and induce CNS neuroinflammation. The pathogens may access the CNS through blood, the nasal olfactory pathways and the GIT. Potential GI pathogens, such as Helicobacter pylori, induce humoral and cellular immune responses that, owing to the sharing of homologous epitopes (molecular mimicry), cross-react with CNS components thereby contributing and possibly perpetuating neural tissue damage. GIT is strictly connected to the CNS and a bi-directional communication exists between them. The brain is involved in regulating the immune and gut system. Conversely, limited attention has been paid on the GIT role in the development and regulation of the CNS autoimmune diseases. The GIT is the primary immune organ with specialized immunoregulatory and anti-inflammatory functions, represented by the gastrointestinal immune system (GIS). This review focuses on the potential GIS and brain dialogue implicated in neurodegenerative diseases. Gaining a better understanding of the relationship between GIS and CNS could provide an insight on the pathogenesis and therapeutic strategies of these disorders.


Assuntos
Encéfalo/metabolismo , Trato Gastrointestinal/imunologia , Inflamação/imunologia , Doenças Neurodegenerativas/imunologia , Anti-Inflamatórios/uso terapêutico , Encéfalo/patologia , Trato Gastrointestinal/metabolismo , Trato Gastrointestinal/patologia , Helicobacter pylori/metabolismo , Helicobacter pylori/patogenicidade , Humanos , Inflamação/patologia , Modelos Biológicos , Doenças Neurodegenerativas/metabolismo , Neuroimunomodulação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...